Currently, there are 52.12M common shares owned by the public and among those 50.91M shares have been available to trade.
The company’s stock has a 5-day price change of 57.99% and 2.69% over the past three months. IVA shares are trading -40.88% year to date (YTD), with the 12-month market performance down to -31.01% lower. It has a 12-month low price of $1.53 and touched a high of $4.75 over the same period. IVA has an average intraday trading volume of 9.69K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 36.23%, 24.58%, and -14.97% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Inventiva ADR (NASDAQ: IVA) shares accounts for 6.46% of the company’s 52.12M shares outstanding.
It has a market capitalization of $139.83M and a beta (3y monthly) value of 0.96. The earnings-per-share (ttm) stands at -$2.23. Price movements for the stock have been influenced by the stock’s volatility, which stands at 10.74% over the week and 7.52% over the month.
Earnings per share for the fiscal year are expected to increase by 17.73%, and 20.14% over the next financial year.
Looking at the support for the IVA, a number of firms have released research notes about the stock. Canaccord Genuity stated their Buy rating for the stock in a research note on October 27, 2023, with the firm’s price target at $12. ROTH MKM coverage for the Inventiva ADR (IVA) stock in a research note released on May 31, 2023 offered a Buy rating with a price target of $11. Societe Generale was of a view on May 19, 2023 that the stock is Buy, while Stifel gave the stock Buy rating on March 17, 2023, issuing a price target of $27. Societe Generale on their part issued Sell rating on November 15, 2022.
